tiprankstipranks
Trending News
More News >
Pharma Foods International Co., Ltd. (JP:2929)
:2929
Japanese Market
Advertisement

Pharma Foods International Co., Ltd. (2929) Price & Analysis

Compare
1 Followers

2929 Stock Chart & Stats


Pharma Foods International Co., Ltd. News

2929 FAQ

What was Pharma Foods International Co., Ltd.’s price range in the past 12 months?
Pharma Foods International Co., Ltd. lowest stock price was ¥722.00 and its highest was ¥1086.00 in the past 12 months.
    What is Pharma Foods International Co., Ltd.’s market cap?
    Pharma Foods International Co., Ltd.’s market cap is ¥27.32B.
      When is Pharma Foods International Co., Ltd.’s upcoming earnings report date?
      Pharma Foods International Co., Ltd.’s upcoming earnings report date is Sep 03, 2025 which is in 21 days.
        How were Pharma Foods International Co., Ltd.’s earnings last quarter?
        Pharma Foods International Co., Ltd. released its earnings results on Jun 10, 2025. The company reported -¥47.24 earnings per share for the quarter, missing the consensus estimate of N/A by -¥47.24.
          Is Pharma Foods International Co., Ltd. overvalued?
          According to Wall Street analysts Pharma Foods International Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Pharma Foods International Co., Ltd. pay dividends?
            Pharma Foods International Co., Ltd. pays a Semiannually dividend of ¥12.5 which represents an annual dividend yield of 2.67%. See more information on Pharma Foods International Co., Ltd. dividends here
              What is Pharma Foods International Co., Ltd.’s EPS estimate?
              Pharma Foods International Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Pharma Foods International Co., Ltd. have?
              Pharma Foods International Co., Ltd. has 29,079,000 shares outstanding.
                What happened to Pharma Foods International Co., Ltd.’s price movement after its last earnings report?
                Pharma Foods International Co., Ltd. reported an EPS of -¥47.24 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.859%.
                  Which hedge fund is a major shareholder of Pharma Foods International Co., Ltd.?
                  Currently, no hedge funds are holding shares in JP:2929

                  Company Description

                  Pharma Foods International Co., Ltd.

                  Pharma Foods International Co., Ltd. (2929) is a Japan-based company primarily engaged in the development and commercialization of functional foods and pharmaceuticals. The company focuses on leveraging its expertise in biotechnology to create health-promoting products that cater to both human and animal health markets. Core products include functional food ingredients, supplements, and pharmaceutical products that are designed to enhance health and well-being.

                  Pharma Foods International Co., Ltd. (2929) Earnings & Revenues

                  2929 Stock 12 Month Forecast

                  Average Price Target

                  ¥916.00
                  ▼(-2.86% Downside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"807":"¥807","890":"¥890","973":"¥973","848.5":"¥848.5","931.5":"¥931.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":916,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥916.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":916,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥916.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":916,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥916.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[807,848.5,890,931.5,973],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,808.24,816.5292307692308,824.8184615384615,833.1076923076923,841.396923076923,849.6861538461538,857.9753846153847,866.2646153846154,874.5538461538462,882.843076923077,891.1323076923077,899.4215384615385,907.7107692307692,{"y":916,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,808.24,816.5292307692308,824.8184615384615,833.1076923076923,841.396923076923,849.6861538461538,857.9753846153847,866.2646153846154,874.5538461538462,882.843076923077,891.1323076923077,899.4215384615385,907.7107692307692,{"y":916,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,808.24,816.5292307692308,824.8184615384615,833.1076923076923,841.396923076923,849.6861538461538,857.9753846153847,866.2646153846154,874.5538461538462,882.843076923077,891.1323076923077,899.4215384615385,907.7107692307692,{"y":916,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":972.37,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":966.53,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":863.36,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":931.49,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":957.77,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":972.37,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":971.86,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":842.74,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":882.17,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":882.17,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":894,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":961.02,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":808.24,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Wakamoto Pharmaceutical Co., Ltd.
                  Fuso Pharmaceutical Industries,Ltd.
                  Daito Pharmaceutical Co., Ltd.
                  Fuji Pharma Co., Ltd.

                  Ownership Overview

                  2.83%94.67%
                  Insiders
                  2.83%
                  Mutual Funds
                  ― Other Institutional Investors
                  94.67% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis